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3D-QSARAbstract Several novel chalcone derivatives containing malonate and pyridine moieties were syn-
thesized, and their structures were conﬁrmed by 1H nuclear magnetic resonance, 13C nuclear mag-
netic resonance, 19F nuclear magnetic resonance, infrared, and elemental analyses. Antiviral
bioassays revealed that most of the compounds exhibited good antiviral activity against cucumber
mosaic virus (CMV) at 500 lg/mL. In particular, compounds 5l and 5n showed signiﬁcant curative
activities against CMV in vivo with 50% effective concentration (EC50) values of 186.2 and
211.5 lg/mL, respectively; these values are even better than that of ningnanmycin (330.5 lg/mL).
A 3D quantitative structure–activity relationship study was carried out using the comparative
molecular ﬁeld analysis technique based on curative activities against CMV. Results revealed good
predictive ability with cross-validated q2 and non-cross-validated r2 values of 0.517 and 0.990,
respectively.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).nuclear
ensional
opodium
pyridine
2 Z. Chen et al.1. Introduction
Cucumber mosaic virus (CMV), a member of Cucumovirus
that affects cucumber and other cucurbits, was ﬁrst described
in detail in 1916 and is known to affect 1200 species in over
100 plant families and cause signiﬁcant economic losses in a
great quantity of vegetable and horticultural crops
(Palukaitis, 1992; Abad et al., 2000; Gallitelli, 2000; Stamova
and Chetelat, 2000; Sulistyowati et al., 2004; Lin et al.,
2010). Ningnanmycin, the most successful registered anti-
plant viral agent, cannot achieve optimal cure rates for the
virus (Chen et al., 2009; Wang et al., 2012; Luo et al., 2013;
Ma et al., 2014). As such, the development of highly efﬁcient,
novel, and environmentally benign agents to control the refrac-
tory virus disease is a signiﬁcant endeavor (Ritzenthaler, 2005;
Song et al., 2009).
1,3-Diarylprop-2-en-1-ones, commonly known as chal-
cones, have received a great deal of interest in the pharmaco-
logical chemistry. Compounds with the chalcone backbone
are reported to possess a wide range of biological activities,
such as nematicide (Gonza´lez and Este´vez-Braun, 1998), anti-
fungal (Zhao et al., 2007), antiallergenic (Yoshimura et al.,
2009), antimicrobial (Bandgar et al., 2010), anticancer
(Vincenzo et al., 2000), antimalarial (Liu et al., 2001), and anti-
feedant (Thirunarayanan and Vanangamudi, 2014) properties.
Malonates are traditionally regarded as important materi-
als for synthesizing the key intermediates of numerous active
substances but rarely found as pharmacophores belonging to
the target compounds (Wheeler, 1984; Woo et al., 1989;
Ragoussis et al., 2004; Brandau et al., 2006). In our previous
work, we designed and synthesized a series of b-amino acid
ester derivatives containing the malonate moiety with
improved antiviral activities against tobacco mosaic virus
(TMV) (Xiao et al., 2014). Pyridine derivatives are an impor-
tant class of bioactive compounds that have a wide spectrum
of activities, including antimicrobial (Patel and Patel, 2012),
herbicidal (Liu et al., 2008), antitumor (Ahmeda et al.,
2009), and insecticidal (Kang et al., 2013) properties.
Using previous ﬁndings as a basis, we aimed to introduce
malonate and pyridine fragments to the parent chalcone skele-
ton by Michael addition to build a novel family of bioactive
molecules. Bioassay results of most of the resultant com-
pounds revealed moderate to good anti-CMV activity. A 3D
quantitative structure–activity relationship (3D-QSAR) study
of 22 target compounds was carried out using the comparative
molecular ﬁeld analysis (CoMFA) technique based on their
curative activities against CMV, and results revealed good pre-
dictive ability. To the best of our knowledge, the present work
is the ﬁrst to report chalcone derivatives containing malonate
and pyridine moieties with potent effects against CMV deter-
mined through 3D-QSAR analysis.
2. Experimental
2.1. Materials and methods
1H nuclear magnetic resonance (1H NMR), 19F nuclear
magnetic resonance (19F NMR), and 13C nuclear magnetic
resonance (13C NMR) (solvent CDCl3) spectral analyses were
performed on a JEOL-ECX500 NMR spectrometer operating
at 500, 475 and 125 MHz at room temperature withPlease cite this article in press as: Chen, Z. et al., Synthesis, antiviral activity, and 3
moieties. Arabian Journal of Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.20tetramethylsilane as the internal standard. Elemental analysis
was performed on an Elementar Vario-III CHN analyzer.
Infrared (IR) spectra were recorded on a Bruker VECTOR
22 spectrometer by using KBr disks. Mass spectral studies were
conducted on an Agilent 5973 organic mass spectrometer. The
melting points of the products were determined by using an
XT-4 binocular microscope (Beijing Tech Instrument Co.,
China) and are reported uncorrected. Analytical thin-layer
chromatography was performed on silica gel GF254 (400
mesh). Column chromatographic puriﬁcation was carried out
using silica gel. All reagents and reactants were purchased
from commercial suppliers and were either of analytical
reagent grade or of chemically pure. All solvents were dried,
deoxygenated, and redistilled prior to use.
2.2. Chemistry
2.2.1. General procedure for synthesizing (E)-3-(4-((6-
chloropyridin-3-yl)methoxy)phenyl)-1-(aryl)prop-2-en-1-ones
(4a–4k)
As shown in Scheme 1, intermediate 3 was synthesized follow-
ing a previously reported method (Choudhary and Juyal,
2011). Substituted acetophenone 1 was reacted with
p-hydroxy benzaldehyde 2 through Claisen–Schmidt aldol con-
densation at 20–25 C to achieve intermediate 3 in good yield.
Then, key intermediates 4a–4k were synthesized as shown in
Scheme 1 by using a previously described method (Zhao
et al., 2007). Intermediate 3 (2.5 mmol), 2-chloro-5-
(chloromethyl) pyridine (2.5 mmol), K2CO3 (7.5 mmol), and
acetone (15 mL) were added to a 25 mL three-neck round-
bottom ﬂask ﬁtted with a magnetic stirring bar. The resulting
mixture was reﬂuxed at 60 C for 12 h, poured into ice water
(20 mL), and then separated. The aqueous phase was acidiﬁed
with 10% HCl to pH 6–7 and ﬁltered. The residue was dried
and recrystallized from ethanol to obtain the key intermediates
4a–4k. The physical characteristics and IR, 1H NMR, 13C
NMR, and elemental data of 4a–4k are provided as supple-
mentary data.
2.2.2. General procedure for synthesizing dimethyl (ethyl) 2-(1-
(4-((6-chloropyridin-3-yl)methoxy)phenyl)-3-oxo-3-
(aryl)phlpropyl)malonates (5a–5v)
The target compounds 5a–5v were synthesized as illustrated in
Scheme 1. A 25 mL round-bottomed ﬂask equipped with a
magnetic stirrer was charged with intermediate 4 (0.3 mmol),
dimethyl malonate (or diethyl malonate) (1.5 mmol), CH3OH
(or C2H5OH) (8 mL), and KOH (0.3 mmol). The resulting
mixture was reﬂuxed and stirred at 70–80 C for 0.5 h. After
pouring into ice water (10 mL), the solution was acidiﬁed to
pH 6–7 with 10% HCl and then extracted with CH2Cl2
(5 mL · 3). The combined organic layer was concentrated
under rotary evaporation, and the crude residue was separated
through column chromatography on silica gel (ethyl aceta-
te/petroleum ether = 1/5 [v/v]) to obtain the target com-
pounds 5a–5v. The physical characteristics and IR, 1H
NMR, 13C NMR, 19F nuclear magnetic resonance (19F
NMR), mass spectra (MS), and elemental data of target com-
pounds 5a–5v are provided below.2.2.2.1. Dimethyl 2-(1-(4-((6-chloropyridin-3-yl)methoxy)phe-
nyl)-3-oxo-3-phenylpropyl)malonate (5a). Yield, 77%; whiteD-QSAR study of novel chalcone derivatives containing malonate and pyridine
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Scheme 1 Synthesis of the target compounds 5a–5v.
Synthesis, antiviral activity, and 3D-QSAR study of chalcone derivatives 3solid; m.p. 89–91 C; IR (KBr, cm1): m 2841–2996 (CAH),
1734 (AOAC‚O), 1674 (Ar0AC‚O), 1458–1609 (C‚C and
benzene and Py-ring), 1298 (CAN), 1234 (ArACAO), 1157
(CH3AOAC‚O), 818 (CACl);
1H NMR (500 MHz, CDCl3,
ppm): d 8.42 (d, 1H, J= 2.25 Hz, Py-2-H), 7.90 (d, 2H,
J= 7.10 Hz, Ar0-2,6-H), 7.71 (dd, 1H, J1 = 2.35 Hz,
J2 = 2.40 Hz, Py-4-H), 7.54 (t, 1H, J1 = 7.35 Hz,
J2 = 7.40 Hz, Ar
0-4-H), 7.43 (t, 2H, J1 = 7.85 Hz,
J2 = 7.60 Hz, Ar
0-3,5-H), 7.34 (d, 1H, J= 8.25 Hz, Py-5-H),
7.20 (d, 2H, J= 8.75 Hz, Ar-2,6-H), 6.84 (d, 2H,
J= 8.65 Hz, Ar-3,5-H), 4.98 (s, 2H, PyACH2A), 4.17–4.13
(m, 1H, ArACHA), 3.82 (d, 1H, J= 9.35 Hz,
ACO2ACHA), 3.74 (s, 3H, ACO2ACH3), 3.54–3.50 (m, 4H,
ACO2ACH3, ACOACHA), 3.44 (dd, 1H, J1 = J2 =
9.20 Hz, ACOACHA); 13C NMR (125 MHz, CDCl3, ppm):
d 197.6, 168.7, 168.2, 157.1, 151.1, 148.7, 138.1, 136.7, 133.3,
133.2, 131.5, 129.3, 128.6, 128.1, 124.3, 114.7, 66.6, 57.4,
52.7, 52.5, 42.4, 40.1; MS (ESI) m/z: 504.3 ([M+ Na]+).
Anal. Calcd for C26H24ClNO6: C, 64.80; H, 5.02; N, 2.91.
Found: C, 64.86; H, 5.19; N, 2.98.
2.2.2.2. Dimethyl 2-(1-(4-((6-chloropyridin-3-yl)methoxy)phe-
nyl)-3-oxo-3-(o-tolyl)propyl)malonate (5b). Yield, 68%;
white solid; m.p. 79–81 C; IR (KBr, cm1): m 2855–2955
(CAH), 1748 (AOAC‚O), 1682 (Ar0AC‚O), 1456–1609
(C‚C and benzene and Py-ring), 1327 (CAN), 1248
(ArACAO), 1157 (CH3AOAC‚O), 829 (CACl);
1H NMR
(500 MHz, CDCl3, ppm): d 8.40 (d, 1H, J = 2.20 Hz, Py-2-
H), 7.69 (dd, 1H, J1 = J2 = 2.40 Hz, Py-4-H), 7.55 (d, 1H,
J = 7.70 Hz, Ar0-6-H), 7.31–7.29 (m, 2H, Ar0-4-H, Py-5-H),
7.21 (t, 1H, J1 = 7.55 Hz, J2 = 7.50 Hz, Ar
0-5-H), 7.14–7.12
(m, 3H, Ar0-3-H, Ar-2,6-H), 6.83 (d, 2H, J= 8.60 Hz, Ar-
3,5-H), 4.98 (s, 2H, PyACH2A), 4.07–4.02 (m, 1H,
ArACHA), 3.78 (d, 1H, J= 9.65 Hz, ACO2ACHA), 3.73 (s,
3H, ACO2ACH3), 3.50–3.45 (m, 4H, ACO2ACH3,
ACOACHA), 3.29 (dd, 1H, J1 = J2 = 9.90 Hz,
ACOACHA), 2.16 (s, 3H, Ar0ACH3);
13C NMR (125 MHz,
CDCl3, ppm): d 202.0, 168.7, 168.1, 157.2, 151.0, 148.8,Please cite this article in press as: Chen, Z. et al., Synthesis, antiviral activity, and 3D
moieties. Arabian Journal of Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.20138.2, 138.0, 137.9, 133.1, 131.8, 131.7, 131.2, 129.5, 128.3,
125.7, 124.3, 114.8, 66.7, 57.5, 52.7, 52.4, 45.5, 40.5, 20.7;
MS (ESI) m/z: 518.3 ([M+ Na]+). Anal. Calcd. for
C27H26ClNO6: C, 65.39; H, 5.28; N, 2.82. Found: C, 65.36;
H, 5.40; N, 2.89.
2.2.2.3. Dimethyl 2-(1-(4-((6-chloropyridin-3-yl)methoxy)phe-
nyl)-3-oxo-3-(m-tolyl)propyl)malonate (5c). Yield, 44%;
white solid; m.p. 75–77 C; IR (KBr, cm1): m 2849–2955
(CAH), 1734 (AOAC‚O), 1684 (Ar0AC‚O), 1458–1616
(C‚C and benzene and Py-ring), 1289 (CAN), 1242
(ArACAO), 1152 (CH3AOAC‚O), 827.5 (CACl);
1H NMR
(500 MHz, CDCl3, ppm): d 8.41 (d, 1H, J= 1.60 Hz, Py-2-
H), 7.71–7.70 (m, 3H, Py-4-H, Ar0-2,6-H), 7.35–7.28 (m, 3H,
Ar0-4,5-H, Py-5-H), 7.21 (d, 2H, J= 8.15 Hz, Ar-2,6-H),
6.84 (d, 2H, J= 8.20 Hz, Ar-3,5-H), 4.97 (s, 2H,
PyACH2A), 4.18–4.14 (m, 1H, ArACHA), 3.84 (d, 1H,
J= 8.50 Hz, ACO2ACHA), 3.73 (s, 3H, ACO2ACH3), 3.55–
3.42 (m, 5H, ACO2ACH3, ACOACHA), 2.37 (s, 3H,
Ar0ACH3);
13C NMR (125 MHz, CDCl3, ppm): d 197.8,
168.8, 168.3, 157.2, 151.1, 148.8, 138.4, 138.3, 136.8, 134.0,
133.5, 131.7, 129.4, 128.7, 128.6, 125.4, 124.3, 114.7, 66.7,
57.5, 52.8, 52.6, 42.6, 40.1, 21.4; MS (ESI) m/z: 518.3
([M+ Na]+). Anal. Calcd for C27H26ClNO6: C, 65.39; H,
5.28; N, 2.82. Found: C, 65.28; H, 5.52; N, 2.96.
2.2.2.4. Dimethyl 2-(1-(4-((6-chloropyridin-3-yl)methoxy)phe-
nyl)-3-oxo-3-(p-tolyl)propyl)malonate (5d). Yield, 44%;
white solid; m.p. 87–89 C; IR (KBr, cm1): m 2886–3032
(CAH), 1749 (AOAC‚O), 1670 (Ar0AC‚O), 1458–1609
(C‚C and benzene and Py-ring), 1271 (CAN), 1232
(ArACAO), 1159 (CH3AOAC‚O), 822 (CACl);
1H NMR
(500 MHz, CDCl3, ppm): d 8.42 (d, 1H, J= 2.25 Hz, Py-2-
H), 7.80 (d, 2H, J= 8.15 Hz, Ar0-2,6-H), 7.72 (dd, 1H,
J1 = J2 = 2.40 Hz, J= 2.35 Hz, Py-4-H), 7.35 (d, 1H,
J= 8.15 Hz, Py-5-H), 7.23–7.19 (m, 4H, Ar-2,6-H, Ar0-3,5-
H), 6.83 (d, 2H, J= 8.60 Hz, Ar-3,5-H), 4.98 (s, 2H,
PyACH2A), 4.16–4.12 (m, 1H, ArACHA), 3.82 (d, 1H,-QSAR study of novel chalcone derivatives containing malonate and pyridine
15.05.003
4 Z. Chen et al.J= 9.40 Hz, ACO2ACHA), 3.73 (s, 3H, ACO2ACH3), 3.52–
3.46 (m, 4H, ACO2ACH3, ACOACHA), 3.40 (dd, 1H,
J1 = 9.20 Hz, J2 = 9.15 Hz, ACOACHA), 2.39 (s, 3H,
Ar0ACH3);
13C NMR (125 MHz, CDCl3, ppm): d 197.8,
168.8, 168.3, 157.2, 151.1, 148.8, 138.4, 138.3, 136.8, 134.0,
133.5, 131.7, 129.4, 128.7, 128.6, 125.4, 124.3, 114.7, 66.7,
57.5, 52.8, 52.6, 42.6, 40.1, 21.4; MS (ESI) m/z: 518.3
([M+ Na]+). Anal. Calcd for C27H26ClNO6: C, 65.39; H,
5.28; N, 2.82. Found: C, 65.17; H, 5.57; N, 2.90.
2.2.2.5. Dimethyl 2-(3-(2-chlorophenyl)-1-(4-((6-chloropyridin-
3-yl)methoxy)phenyl)-3-oxopropyl)malonate (5e). Yield, 70%;
white solid; m.p. 97–99 C; IR (KBr, cm1): m 2849–3065
(CAH), 1721 (AOAC‚O), 1701 (Ar0AC‚O), 1458–1611
(C‚C and benzene and Py-ring), 1319 (CAN), 1258
(ArACAO), 1161 (CH3AOAC‚O), 820 (CACl);
1H NMR
(500 MHz, CDCl3, ppm): d 8.43 (d, 1H, J = 2.15 Hz, Py-2-
H), 7.73 (dd, 1H, J1 = 2.35 Hz, J2 = 2.30 Hz, Py-4-H), 7.36–
7.32 (m, 3H, Ar0-4,6-H, Py-5-H), 7.26–7.21 (m, 1H, Ar0-5-H),
7.19 (d, 1H, J= 7.05 Hz, Ar0-3-H), 7.16 (d, 2H, J= 8.65 Hz,
Ar-2,6-H), 6.84 (d, 2H, J= 8.65 Hz, Ar-3,5-H), 5.01 (s, 2H,
PyACH2A), 4.07–4.02 (m, 1H, ArACHA), 3.78–3.75 (m, 4H,
ACO2ACHA, ACO2ACH3), 3.53–3.48 (m, 4H, ACO2ACH3,
ACOACHA), 3.42 (dd, 1H, J1 = 9.55 Hz, J2 = 9.65 Hz,
ACOACHA); 13C NMR (125 MHz, CDCl3, ppm): d 200.7,
168.5, 168.0, 157.2, 151.1, 148.7, 139.0, 138.1, 132.8, 131.7,
131.5, 130.7, 130.4, 129.5, 129.0, 126.8, 124.3, 114.7, 66.6,
57.3, 52.8, 52.5, 46.5, 40.1; MS (ESI) m/z: 538.3
([M+Na]+). Anal. Calcd for C26H23Cl2NO6: C, 60.48; H,
4.49; N, 2.71. Found: C, 60.55; H, 4.64; N, 2.83.
2.2.2.6. Dimethyl 2-(3-(3-chlorophenyl)-1-(4-((6-chloropy-
ridin-3-yl)methoxy)phenyl)-3-oxopropyl)malonae (5f). Yield,
50%; white solid; m.p. 77–79 C; IR (KBr, cm1): m 2849–
3065 (CAH), 1734 (AOAC‚O), 1684 (Ar0AC‚O), 1458–
1609 (C‚C and benzene and Py-ring), 1311 (CAN), 1244
(ArACAO), 1155 (CH3AOAC‚O), 831 (CACl);
1H NMR
(500 MHz, CDCl3, ppm): d 8.41 (d, 1H, J= 2.15 Hz, Py-2-
H), 7.84 (s, 1H, Ar0-2-H), 7.79 (d, 1H, J= 7.90 Hz, Ar0-6-
H), 7.72 (dd, 1H, J1 = 2.30 Hz, J2 = 2.40 Hz, Py-4-H), 7.51–
7.49 (m, 1H, Ar0-4-H), 7.39–7.33 (m, 2H, Ar0-5-H, Py-5-H),
7.20 (d, 2H, J= 8.60 Hz, Ar-2,6-H), 6.85 (d, 2H,
J= 8.60 Hz, Ar-3,5-H), 4.99 (s, 2H, PyACH2A), 4.15–4.10
(m, 1H, ArACHA), 3.82 (d, 1H, J = 9.45 Hz,
ACO2ACHA), 3.74 (s, 3H, ACO2ACH3), 3.53–3.48 (m, 4H,
ACO2ACH3, ACOACHA), 3.41 (dd, 1H, J1 = 9.25 Hz,
J2 = 9.20 Hz, ACOACHA);
13C NMR (125 MHz, CDCl3,
ppm): d 196.5, 168.8, 168.2, 157.3, 151.0, 148.7, 138.4, 138.2,
134.9, 133.2, 133.1, 131.7, 130.7, 130.1, 129.4, 128.2, 126.3,
124.4, 114.8, 66.6, 57.3, 52.9, 52.6, 42.7, 40.1; MS (ESI) m/z:
538.3 ([M +Na]+). Anal. Calcd for C26H23Cl2NO6: C,
60.48; H, 4.49; N, 2.71. Found: C, 60.58; H, 4.72; N, 2.75.
2.2.2.7. Dimethyl 2-(3-(4-chlorophenyl)-1-(4-((6-chloropyridin-
3-yl)methoxy)phenyl)-3-oxopropyl)malonate (5g). Yield, 57%;
white solid; m.p. 103–105 C; IR (KBr, cm1): m 2887–3088
(CAH), 1734 (AOAC‚O), 1684 (Ar0AC‚O), 1458–1616
(C‚C and benzene and Py-ring), 1308 (CAN), 1248
(ArACAO), 1159 (CH3AOAC‚O), 833 (CACl);
1H NMR
(500 MHz, CDCl3, ppm): d 8.42 (d, 1H, J= 2.35 Hz,
Py-2-H), 7.84 (d, 2H, J= 8.55 Hz, Ar0-2,6-H), 7.71
(dd, 1H, J1 = 2.55 Hz, J2 = 2.40 Hz, Py-4-H), 7.41 (d, 2H,Please cite this article in press as: Chen, Z. et al., Synthesis, antiviral activity, and 3
moieties. Arabian Journal of Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.20J= 8.60 Hz, Ar0-3,5-H), 7.35 (d, 1H, J= 8.15 Hz, Py-5-H),
7.18 (d, 2H, J= 8.65 Hz, Ar-2,6-H), 6.84 (d, 2H,
J= 8.65 Hz, Ar-3,5-H), 4.98 (s, 2H, PyACH2A), 4.13–4.09
(m, 1H, ArACHA), 3.80 (d, 1H, J= 9.35 Hz, ACO2ACHA),
3.74 (s, 3H, ACO2ACH3), 3.52–3.48 (m, 4H, ACO2ACH3,
ACOACHA), 3.38 (dd, 1H, J1 = 9.30 Hz, J2 = 9.35 Hz,
ACOACHA); 13C NMR (125 MHz, CDCl3, ppm): d 196.4,
168.7, 168.1, 157.2, 151.2, 148.7, 139.6, 138.1, 135.0, 133.0,
131.5, 129.5, 129.3, 128.9, 124.3, 114.7, 66.6, 57.3, 52.7, 52.5,
42.4, 40.1; MS (ESI) m/z: 538.3 ([M+Na]+). Anal. Calcd
for C26H23Cl2NO6: C, 60.48; H, 4.49; N, 2.71. Found: C,
60.53; H, 4.69; N, 2.86.2.2.2.8. Dimethyl 2-(1-(4-((6-chloropyridin-3-yl)methoxy)phe-
nyl)-3-(2,4-dichlorophenyl)-3-oxopropyl)malonate (5h). Yield,
51%; white solid; m.p. 109–111 C; IR (KBr, cm1): m 2864–
3069 (CAH), 1741 (AOAC‚O), 1699 (Ar0AC‚O), 1456–
1609 (C‚C and benzene and Py-ring), 1280 (CAN), 1252
(ArACAO), 1159 (CH3AOAC‚O), 831 (CACl);
1H NMR
(500 MHz, CDCl3, ppm): d 8.43 (d, 1H, J= 2.30 Hz, Py-2-
H), 7.73 (dd, 1H, J1 = J2 = 2.40 Hz, Py-4-H), 7.38 (d, 1H,
J= 1.85 Hz, Ar0-6-H), 7.36 (d, 1H, J= 8.15 Hz, Py-5-H),
7.23 (dd, 1H, J1 = 1.80 Hz, J2 = 1.95 Hz, Ar
0-3-H), 7.17 (d,
1H, J= 8.25 Hz, Ar0-5-H), 7.14 (d, 2H, J= 8.70 Hz, Ar-2,6-
H), 6.84 (d, 2H, J= 8.70 Hz, Ar-3,5-H), 5.00 (s, 2H,
PyACH2A), 4.04–4.00 (m, 1H, ArACHA), 3.76–3.74 (m, 4H,
ACO2ACHA, ACO2ACH3), 3.52–3.47 (m, 4H, ACO2ACH3,
ACOACHA), 3.39 (dd, 1H, J1 = 9.70 Hz, J2 = 9.60 Hz,
ACOACHA); 13C NMR (125 MHz, CDCl3, ppm): d 199.5,
168.5, 168.0, 148.7, 138.1, 132.7, 130.3, 129.5, 127.2, 124.3,
114.8, 66.7, 57.2, 52.8, 52.5, 46.5, 40.2; MS (ESI) m/z: 572.2
([M+ Na]+). Anal. Calcd for C26H22Cl3NO6: C, 56.69; H,
4.03; N, 2.54. Found: C, 56.55; H, 4.11; N, 2.82.
2.2.2.9. Dimethyl 2-(1-(4-((6-chloropyridin-3-yl)methoxy)phe-
nyl)-3-(4-ethoxyphenyl)-3-oxopropyl)malonate (5i). Yield,
46%; white solid; m.p. 93–95 C; IR (KBr, cm1): m 2891–
2990 (CAH), 1732 (AOAC‚O), 1667 (Ar0AC‚O), 1458–
1603 (C‚C and benzene and Py-ring), 1308 (CAN), 1234
(ArACAO), 1179 (ACH2AOAAr0), 1157 (CH3AOAC‚O),
831 (CACl); 1H NMR (500 MHz, CDCl3, ppm): d 8.42 (d,
1H, J = 2.25 Hz, Py-2-H), 7.88 (d, 2H, J= 8.95 Hz, Ar0-2,6-
H), 7.71 (dd, 1H, J1 = 2.50 Hz, J2 = 2.40 Hz, Py-4-H), 7.34
(d, 1H, J= 8.25 Hz, Py-5-H), 7.19 (d, 2H, J= 8.70 Hz, Ar-
2,6-H), 6.88 (d, 2H, J = 8.90 Hz, Ar0-3,5-H), 6.83 (d, 2H,
J= 8.70 Hz, Ar-3,5-H), 4.98 (s, 2H, PyACH2A), 4.16–4.05
(m, 3H, ArACHA, Ar0AOCH2A), 3.81 (d, 1H, J= 9.40 Hz,
ACO2ACHA), 3.73 (s, 3H, ACO2ACH3), 3.52 (s, 3H,
ACO2ACH3), 3.45 (dd, 1H, J1 = 4.70 Hz, J2 = 4.65 Hz,
ACOACHA), 3.36 (dd, 1H, J1 = J2 = 9.25 Hz, ACOACHA),
1.43 (t, 3H, J1 = J2 = 7.05 Hz, Ar
0AOCH2ACH3);
13C NMR
(125 MHz, CDCl3, ppm): d 196.0, 168.8, 168.2, 162.9, 157.1,
153.7, 148.7, 138.1, 133.4, 131.5, 130.4, 129.6, 129.3, 124.3,
114.6, 114.1, 66.6, 63.7, 57.4, 52.7, 52.5, 42.1, 40.3, 14.7; MS
(ESI) m/z: 548.3 ([M+Na]+). Anal. Calcd for C28H28ClNO7:
C, 63.94; H, 5.37; N, 2.66. Found: C, 63.92; H, 5.46; N, 2.78.
2.2.2.10. Dimethyl 2-(1-(4-((6-chloropyridin-3-yl)methoxy)-
phenyl)-3-(4-ﬂuorophenyl)-3-oxopropyl)malonate (5j). Yield,
65%; white solid; m.p. 74–76 C; IR (KBr, cm1): m 2849–
3067 (CAH), 1734 (AOAC‚O), 1684 (Ar0AC‚O), 1458–D-QSAR study of novel chalcone derivatives containing malonate and pyridine
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(CAF), 1227 (ArACAO), 1155 (CH3AOAC‚O), 831
(CACl); 1H NMR (500 MHz, CDCl3, ppm): d 8.42 (d, 1H,
J= 2.20 Hz, Py-2-H), 7.95–7.92 (m, 2H, Ar0-2,6-H), 7.71
(dd, 1H, J1 = 2.40 Hz, J2 = 2.45 Hz, Py-4-H), 7.34 (d, 1H,
J= 8.15 Hz, Py-5-H), 7.18 (d, 2H, J= 8.70 Hz, Ar-2,6-H),
7.10 (t, 2H, J1 = 8.55 Hz, J2 = 8.60 Hz, Ar
0-3,5-H), 6.84 (d,
2H, J= 8.65 Hz, Ar-3,5-H), 4.98 (s, 2H, PyACH2A), 4.14–
4.10 (m, 1H, ArACHA), 3.81 (d, 1H, J= 9.35 Hz,
ACO2ACHA), 3.74 (s, 3H, ACO2ACH3), 3.53–3.49 (m, 4H,
ACO2ACH3, ACOACHA), 3.39 (dd, 1H, J1 = J2 =
9.40 Hz, ACOACHA); 13C NMR (125 MHz, CDCl3, ppm):
d 196.1, 168.8, 168.2, 166.8, 164.8, 157.3, 151.2, 148.8, 138.2,
133.2, 131.6, 130.9, 130.8, 129.4, 124.4, 115.9, 115.7, 114.8,
66.7, 57.4, 52.8, 52.6, 42.5, 40.3; 19F NMR (470 MHz,
CDCl3, ppm): d 104.91; MS (ESI) m/z: 522.3 ([M+ Na]+).
Anal. Calcd for C26H23ClFNO6: C, 62.47; H, 4.64; N, 2.80.
Found: C, 62.09; H, 4.83; N, 2.91.
2.2.2.11. Dimethyl 2-(1-(4-((6-chloropyridin-3-yl)methoxy)-
phenyl)-3-(4-isopropylphenyl)-3-oxopropyl)malonate (5k).
Yield, 52%; white solid; m.p. 61–63 C; IR (KBr, cm1): m
2874–3046 (CAH), 1748 (AOAC‚O), 1674 (Ar0AC‚O),
1458–1609 (C‚C and benzene and Py-ring), 1314 (CAN),
1262 (ArACAO), 1150 (CH3AOAC‚O), 830 (CACl);
1H
NMR (500 MHz, CDCl3, ppm): d 8.42 (d, 1H, J= 2.25 Hz,
Py-2-H), 7.84 (d, 2H, J= 8.35 Hz, Ar0-2,6-H), 7.72 (dd, 1H,
J1 = 2.55 Hz, J2 = 2.40 Hz, Py-4-H), 7.34 (d, 1H,
J = 8.25 Hz, Py-5-H), 7.28 (d, 2H, J= 8.25 Hz, Ar-2,6-H),
7.20 (d, 2H, J= 8.70 Hz, Ar0-3,5-H), 6.83 (d, 2H,
J= 8.75 Hz, Ar-3,5-H), 4.98 (s, 2H, PyACH2A), 4.17–4.12
(m, 1H, ArACHA), 3.82 (d, 1H, J= 9.55 Hz,
ACO2ACHA), 3.73 (s, 3H, ACO2ACH3), 3.52 (s, 3H,
ACO2ACH3), 3.48 (dd, 1H, J1 = 4.85 Hz, J2 = 4.80 Hz,
ACOACHA), 3.41 (dd, 1H, J1 = J2 = 9.15 Hz,
ACOACHA), 2.99–2.90 (m, 1H, Ar0ACHA), 1.25 (d, 6H,
J= 6.90 Hz, Ar0ACHA(CH3)2);
13C NMR (125 MHz,
CDCl3, ppm): d 197.1, 168.7, 168.2, 157.1, 154.7, 151.1,
148.7, 138.2, 134.6, 133.4, 131.5, 129.3, 128.3, 126.7, 124.3,
114.6, 66.6, 57.4, 52.7, 52.5, 42.3, 40.1, 34.2, 23.7; MS (ESI)
m/z: 546.3 ([M+ Na]+). Anal. Calcd for C29H30ClNO6: C,
66.47; H, 5.77; N, 2.67. Found: C, 66.56; H, 5.77; N, 2.78.
2.2.2.12. Diethyl 2-(1-(4-((6-chloropyridin-3-yl)methoxy)phe-
nyl)-3-oxo-3-phenylpropyl)malonate (5l). Yield, 71%; white
solid; m.p. 82–84 C; IR (KBr, cm1): m 2874–3065 (CAH),
1740 (AOAC‚O), 1676 (Ar0AC‚O), 1458–1616 (C‚C and
benzene and Py-ring), 1292 (CAN), 1262 (ArACAO), 1150
(ACH2AOAC‚O), 824 (CACl);
1H NMR (500 MHz,
CDCl3, ppm): d 8.41 (d, 1H, J= 2.15 Hz, Py-2-H), 7.90 (d,
2H, J= 7.75 Hz, Ar0-2,6-H), 7.72 (dd, 1H, J1 = 2.40 Hz,
J2 = 2.30 Hz, Py-4-H), 7.54 (t, 1H, J1 = 7.35 Hz,
J2 = 7.45 Hz, Ar
0-4-H), 7.43 (t, 2H, J1 = 7.65 Hz,
J2 = 7.70 Hz, Ar
0-3,5-H), 7.34 (d, 1H, J= 8.20 Hz, Py-5-H),
7.20 (d, 2H, J= 8.60 Hz, Ar-2,6-H), 6.83 (d, 2H,
J= 8.60 Hz, Ar-3,5-H), 4.98 (s, 2H, PyACH2A), 4.26–4.17
(m, 2H, ACO2ACH2A), 4.16–4.11 (m, 1H, ArACHA), 3.97
(q, 2H, ACO2ACH2A), 3.78 (d, 1H, J= 9.75 Hz,
ACO2ACHA), 3.52 (dd, 1H, J1 = 4.30 Hz, J2 = 4.20 Hz,
ACOACHA), 3.41 (dd, 1H, J1 = 9.60 Hz, J2 = 9.55 Hz,
ACOACHA), 1.25 (t, 3H, J1 = 7.25 Hz, J2 = 7.00 Hz,
ACO2ACH2ACH3), 1.03 (t, 3H, J1 = 7.25 Hz, J2 = 7.00 Hz,Please cite this article in press as: Chen, Z. et al., Synthesis, antiviral activity, and 3D
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13C NMR (125 MHz, CDCl3, ppm): d
197.6, 168.3, 167.7, 157.1, 151.1, 148.7, 138.1, 136.7, 133.3,
133.1, 131.5, 129.5, 128.6, 128.1, 124.2, 114.6 66.6, 61.7, 61.4,
57.7, 42.8, 40.1, 14.1, 13.8; MS (ESI) m/z: 532.4
([M+ Na]+). Anal. Calcd for C28H28ClNO6: C, 65.94; H,
5.53; N, 2.75. Found: C, 65.87; H, 5.93; N, 2.81.
2.2.2.13. Diethyl 2-(1-(4-((6-chloropyridin-3-yl)methoxy)phe-
nyl)-3-oxo-3-(o-tolyl)propyl)malonate (5m). Yield, 50%;
white solid; m.p. 52–54 C; IR (KBr, cm1) m: 2849–3065
(CAH), 1734 (AOAC‚O), 1684 (Ar0AC‚O), 1458–1616
(C‚C and benzene and Py-ring), 1319 (CAN), 1244
(ArACAO), 1179 (ACH2AOAC‚O), 828 (CACl);
1H NMR
(500 MHz, CDCl3, ppm): d 8.41 (d, 1H, J= 2.25 Hz, Py-2-
H), 7.70 (dd, 1H, J1 = J2 = 2.40 Hz, Py-4-H), 7.54 (d, 1H,
J= 7.80 Hz, Ar0-6-H), 7.33–7.30 (m, 2H, Ar0-4-H, Py-5-H),
7.22 (t, 1H, J1 = 7.55 Hz, J2 = 7.45 Hz, Ar
0-5-H), 7.15–7.12
(m, 3H, Ar0-3-H, Ar-2,6-H), 6.82 (d, 2H, J= 8.65 Hz, Ar-
3,5-H), 4.98 (s, 2H, PyACH2A), 4.26–4.17 (m, 2H,
ACO2ACH2A), 4.05–4.00 (m, 1H, ArACHA), 3.95 (q, 2H,
ACO2ACH2A), 3.73 (d, 1H, J= 9.90 Hz, ACO2ACHA),
3.48 (dd, 1H, J1 = 4.35 Hz, J2 = 4.30 Hz, ACOACHA),
3.26 (dd, 1H, J1 = J2 = 10.20 Hz, ACOACHA), 2.15 (s, 3H,
Ar0ACH3), 1.26 (t, 3H, J1 = 7.15 Hz, J2 = 7.10 Hz,
ACO2ACH2ACH3), 1.01 (t, 3H, J1 = 7.15 Hz, J2 = 7.10 Hz,
ACO2ACH2ACH3);
13C NMR (125 MHz, CDCl3, ppm): d
202.1, 168.3, 167.7, 157.2, 151.1, 148.8, 138.2, 138.0, 137.9,
133.1, 131.8, 131.7, 131.2, 129.7, 128.3, 125.7, 124.3, 114.8,
66.7, 61.7, 61.4, 57.8, 45.8, 40.6, 20.7, 14.1, 13.9; MS (ESI)
m/z: 546.4 ([M+ Na]+). Anal. Calcd for C29H30ClNO6: C,
66.47; H, 5.77; N, 2.67. Found: C, 66.39; H, 6.08; N, 2.83.
2.2.2.14. Diethyl 2-(1-(4-((6-chloropyridin-3-yl)methoxy)phe-
nyl)-3-oxo-3-(m-tolyl)propyl)malonate (5n). Yield, 52%;
white solid; m.p. 61–63 C; IR (KBr, cm1): m 2928–3065
(CAH), 1740 (AOAC‚O), 1674 (Ar0AC‚O), 1458–1609
(C‚C and benzene and Py-ring), 1265 (CAN), 1242
(ArACAO), 1150 (ACH2AOAC‚O), 822 (CACl);
1H NMR
(500 MHz, CDCl3, ppm): d 8.40 (d, 1H, J = 2.05 Hz, Py-2-
H), 7.71–7.70 (m, 3H, Py-4-H, Ar0-2,6-H), 7.34–7.28 (m, 3H,
Ar0-4,5-H, Py-5-H), 7.22 (d, 2H, J= 8.60 Hz, Ar-2,6-H),
6.83 (d, 2H, J= 8.70 Hz, Ar-3,5-H), 4.97 (s, 2H,
PyACH2A), 4.26–4.13 (m, 3H, ACO2ACH2A, ArACHA),
3.97 (q, 2H, ACO2ACH2A), 3.80 (d, 1H, J= 9.75 Hz,
ACO2ACHA), 3.50 (dd, 1H, J1 = 4.45 Hz, J2 = 4.35 Hz,
ACOACHA), 3.43 (dd, 1H, J1 = J2 = 9.35 Hz, ACOACHA),
2.36 (s, 3H, Ar0ACH3), 1.25 (t, 3H, J1 = 7.15 Hz,
J2 = 7.10 Hz, ACO2ACH2ACH3), 1.03 (t, 3H, J1 = 7.25 Hz,
J2 = 7.00 Hz, ACO2ACH2ACH3);
13C NMR (125 MHz,
CDCl3, ppm): d 197.8, 168.4, 167.9, 157.1, 151.1, 148.8, 138.4,
138.2, 136.8, 134.0, 133.6, 131.7, 129.6, 128.7, 128.5, 125.4,
124.3, 114.7, 66.6, 61.8, 61.4, 57.7, 42.9, 40.1, 21.4, 14.1, 13.9;
MS (ESI) m/z: 546.4 ([M+Na]+). Anal. Calcd for
C29H30ClNO6: C, 66.47; H, 5.77; N, 2.67. Found: C, 66.26; H,
6.10; N, 2.72.
2.2.2.15. Diethyl 2-(1-(4-((6-chloropyridin-3-yl)methoxy)phe-
nyl)-3-oxo-3-(p-tolyl)propyl)malonate (5o). Yield, 44%;
white solid; m.p. 87–89 C; IR (KBr, cm1): m 2851–3055
(CAH), 1734 (AOAC‚O), 1684 (Ar0AC‚O), 1458–1609
(C‚C and benzene and Py-ring), 1289 (CAN), 1244
(ArACAO), 1179 (ACH2AOAC‚O), 829 (CACl);
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7.79 (d, 2H, J= 8.15 Hz, Ar0-2,6-H), 7.68 (dd, 1H,
J1 = J2 = 2.35 Hz, Py-4-H), 7.29 (d, 1H, J= 8.15 Hz, Py-5-
H), 7.21–7.20 (m, 4H, Ar-2,6-H, Ar0-3,5-H), 6.82 (d, 2H,
J= 8.60 Hz, Ar-3,5-H), 4.95 (s, 2H, PyACH2A), 4.25–4.12
(m, 3H, ACO2ACH2A, ArACHA), 3.95 (q, 2H,
ACO2ACH2A), 3.80 (d, 1H, J= 9.75 Hz, ACO2ACHA),
3.49 (dd, 1H, J1 = J2 = 4.40 Hz, ACOACHA), 3.39 (dd,
1H, J1 = J2 = 9.50 Hz, ACOACHA), 2.36 (s, 3H,
Ar0ACH3), 1.24 (t, 3H, J1 = 7.05 Hz, J2 = 7.15 Hz,
ACO2ACH2ACH3), 1.02 (t, 3H, J1 = 7.15 Hz, J2 = 7.05 Hz,
ACO2ACH2ACH3);
13C NMR (125 MHz, CDCl3, ppm): d
197.3, 168.4, 167.8, 157.2, 151.0, 148.7, 143.9, 138.2, 134.4,
133.6, 131.8, 129.6, 129.3, 128.3, 124.2, 114.7, 66.7, 61.7,
61.4, 57.8, 42.7, 40.3, 21.6, 14.1, 13.9; MS (ESI) m/z: 546.4
([M+ Na]+). Anal. Calcd for C29H30ClNO6: C, 66.47; H,
5.77; N, 2.67. Found: C, 66.18; H, 5.84; N, 2.74.
2.2.2.16. Diethyl 2-(3-(2-chlorophenyl)-1-(4-((6-chloropyridin-
3-yl)methoxy)phenyl)-3-oxopropyl)malonate (5p). Yield,
60%; white solid; m.p. 63–65 C; IR (KBr, cm1): m 2911–
3050 (CAH), 1726 (AOAC‚O), 1680 (Ar0AC‚O), 1458–
1609 (C‚C and benzene and Py-ring), 1294 (CAN), 1236
(ArACAO), 1155 (–CH2–OAC‚O), 829 (CACl);
1H NMR
(500 MHz, CDCl3, ppm): d 8.43 (d, 1H, J= 2.15 Hz, Py-2-
H), 7.73 (dd, 1H, J1 = 2.30 Hz, J2 = 2.35 Hz, Py-4-H), 7.36–
7.31 (m, 3H, Ar0-4,6-H, Py-5-H), 7.24–7.21 (m, 1H, Ar0-5-H),
7.18–7.15 (m, 3H, Ar0-3-H, Ar-2,6-H), 6.83 (d, 2H,
J= 8.60 Hz, Ar-3,5-H), 5.01 (s, 2H, PyACH2–), 4.24–4.18
(m, 2H, ACO2ACH2A), 4.06–4.01 (m, 1H, ArACHA), 3.96
(q, 2H, ACO2ACH2A), 3.72 (d, 1H, J= 9.85 Hz,
ACO2ACHA), 3.50 (dd, 1H, J1 = 4.45 Hz, J2 = 4.40 Hz,
ACOACHA), 3.41 (dd, 1H, J1 = J2 = 9.90 Hz, ACOACHA),
1.26 (t, 3H, J1 = 7.15 Hz, J2 = 7.05 Hz, ACO2ACH2ACH3),
1.03 (t, 3H, J1 = 7.15 Hz, J2 = 7.10 Hz, ACO2ACH2ACH3);
13C NMR (125 MHz, CDCl3, ppm): d 200.9, 168.2, 167.7,
157.2, 151.2, 148.8, 139.2, 138.2, 133.0, 131.8, 131.6, 130.8,
130.5, 129.8, 129.0, 126.9, 124.3, 114.7, 66.7, 61.8, 61.5, 57.7,
46.9, 40.2, 14.2, 13.9; MS (ESI) m/z: 566.4 ([M+Na]+). Anal.
Calcd for C28H27Cl2NO6: C, 61.77; H, 5.00; N, 2.57. Found:
C, 61.36; H, 5.36; N, 2.69.
2.2.2.17. Diethyl 2-(3-(3-chlorophenyl)-1-(4-((6-chloropyridin-
3-yl)methoxy)phenyl)-3-oxopropyl)malonate (5q). Yield,
53%; white solid; m.p. 59–61 C; IR (KBr, cm1): m 2905–
3065 (CAH), 1740 (AOAC‚O), 1684 (Ar0AC‚O), 1458–
1609 (C‚C and benzene and Py-ring), 1294 (CAN), 1256
(ArACAO), 1150 (ACH2AOAC‚O), 824 (CACl);
1H NMR
(500 MHz, CDCl3, ppm): d 8.42 (d, 1H, J= 2.20 Hz, Py-2-
H), 7.84 (t, 1H, J1 = 1.65 Hz, J2 = 1.70 Hz, Ar
0-2-H), 7.79
(d, 1H, J= 7.90 Hz, Ar0-6-H), 7.71 (dd, 1H, J1 = 2.40 Hz,
J2 = 2.35 Hz, Py-4-H), 7.52–7.50 (m, 1H, Ar
0-4-H), 7.39–
7.34 (m, 2H, Ar0-5-H, Py-5-H), 7.19 (d, 2H, J= 8.65 Hz,
Ar-2,6-H), 6.83 (d, 2H, J= 8.60 Hz, Ar-3,5-H), 4.99 (s, 2H,
PyACH2A), 4.25–4.17 (m, 2H, ACO2ACH2A), 4.13–4.09 (m,
1H, ArACHA), 3.97 (q, 2H, ACO2ACH2A), 3.77 (d, 1H,
J= 9.75 Hz, ACO2ACHA), 3.50 (dd, 1H, J1 = 4.25 Hz,
J2 = 4.30 Hz, ACOACHA), 3.38 (dd, 1H, J1 = 9.55 Hz,
J2 = 9.45 Hz, ACOACHA), 1.26 (t, 3H, J1 = 7.25 Hz,
J2 = 7.00 Hz, ACO2ACH2ACH3), 1.04 (t, 3H, J1 = J2 =
7.10 Hz, ACO2ACH2ACH3);
13C NMR (125 MHz, CDCl3,
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m/z: 566.3 ([M +Na]+). Anal. Calcd for C28H27Cl2NO6: C,
61.77; H, 5.00; N, 2.57. Found: C, 61.39; H, 5.16; N, 2.73.2.2.2.18. Diethyl 2-(3-(4-chlorophenyl)-1-(4-((6-chloropyridin-
3-yl)methoxy)phenyl)-3-oxopropyl)malonate (5r). Yield,
50%; white solid; m.p. 67–69 C; IR (KBr, cm1): m 2911–
3050 (CAH), 1726 (AOAC‚O), 1680 (Ar0AC‚O), 1458–
1609 (C‚C and benzene and Py-ring), 1294 (CAN), 1236
(ArACAO), 1159 (ACH2AOAC‚O), 824 (C-Cl);
1H NMR
(500 MHz, CDCl3, ppm): d 8.40 (d, 1H, J= 2.20 Hz, Py-2-
H), 7.84 (d, 2H, J= 8.55 Hz, Ar0-2,6-H),7.71 (dd, 1H,
J1 = 2.45 Hz, J2 = 2.30 Hz, Py-4-H), 7.40 (d, 2H,
J= 8.50 Hz, Ar0-3,5-H), 7.34 (d, 1H, J= 8.25 Hz, Py-5-H),
7.18 (d, 2H, J= 8.70 Hz, Ar-2,6-H), 6.83 (d, 2H,
J= 8.60 Hz, Ar-3,5-H), 4.98 (s, 2H, PyACH2A), 4.26–4.15
(m, 2H, ACO2ACH2A), 4.12–4.07 (m, 1H, ArACHA), 3.97
(q, 2H, ACO2ACH2A), 3.77 (d, 1H, J= 9.75 Hz,
ACO2ACHA), 3.51 (dd, 1H, J1 = 4.20 Hz, J2 = 4.25 Hz,
ACOACHA), 3.35 (dd, 1H, J1 = 9.75 Hz, J2 = 9.65 Hz,
ACOACHA), 1.25 (t, 3H, J1 = 7.25 Hz, J2 = 7.00 Hz,
ACO2ACH2ACH3), 1.03 (t, 3H, J1 = 7.05 Hz, J2 = 7.15 Hz,
ACO2ACH2ACH3);
13C NMR (125 MHz, CDCl3, ppm): d
196.5, 168.3, 167.7, 157.1, 151.1, 148.7, 139.5, 138.1, 135.0,
133.1, 131.5, 129.6, 129.4, 128.9, 124.2, 114.6, 66.6, 61.7,
61.4, 57.6, 42.8, 40.2, 14.0, 13.8; MS (ESI) m/z: 566.3
([M+ Na]+). Anal. Calcd for C28H27Cl2NO6: C, 61.77; H,
5.00; N, 2.57. Found: C, 61.52; H, 5.12; N, 2.64.
2.2.2.19. Diethyl 2-(1-(4-((6-chloropyridin-3-yl)methoxy)phe-
nyl)-3-(2,4-dichlorophenyl)-3-oxopropyl)malonate (5s). Yield,
41%; white solid; m.p. 71–73 C; IR (KBr, cm1): m 2849–3088
(CAH), 1734 (AOAC‚O), 1684 (Ar0AC‚O), 1458–1609
(C‚C and benzene and Py-ring), 1300 (CAN), 1244
(ArACAO), 1153 (ACH2AOAC‚O), 826 (CACl);
1H NMR
(500 MHz, CDCl3, ppm): d 8.43 (d, 1H, J = 2.25 Hz, Py-2-
H), 7.73 (dd, 1H, J1 = 2.40 Hz, J2 = 2.50 Hz, Py-4-H), 7.37–
7.34 (m, 2H, Ar0-6-H, Py-5-H), 7.22 (dd, 1H, J1 = 2.05 Hz,
J2 = 1.75 Hz, Ar
0-3-H), 7.17–7.14 (m, 3H, Ar0-5-H, Ar-2,6-
H), 6.83 (d, 2H, J= 8.65 Hz, Ar-3,5-H), 5.00 (s, 2H,
PyACH2A), 4.23–4.19 (m, 2H, ACO2ACH2A), 4.03–3.94 (m,
3H, ArACHA, ACO2ACH2A), 3.71 (d, 1H, J= 9.75 Hz,
ACO2ACHA), 3.49 (dd, 1H, J1 = J2 = 4.40 Hz,
ACOACHA), 3.38 (dd, 1H, J1 = 10.05 Hz, J2 = 9.95 Hz,
ACOACHA), 1.26 (t, 3H, J1 = 7.05 Hz, J2 = 7.20 Hz,
ACO2ACH2ACH3), 1.03 (t, 3H, J1 = 7.00 Hz, J2 = 7.25 Hz,
ACO2ACH2ACH3);
13C NMR (125 MHz, CDCl3, ppm): d
199.6, 168.2, 167.6, 157.3, 151.2, 148.8, 138.1, 137.3, 132.9,
132.0, 131.6, 130.3, 129.7, 127.3, 124.3, 114.8, 66.7, 61.8,
61.5, 57.6, 46.8, 40.3, 14.1, 13.9; MS (ESI) m/z: 600.3
([M+ Na]+). Anal. Calcd for C28H26Cl3NO6: C, 58.10; H,
4.53; N, 2.42. Found: C, 57.86; H, 4.84; N, 2.33.
2.2.2.20. Diethyl 2-(1-(4-((6-chloropyridin-3-yl)methoxy)phe-
nyl)-3-(4-ethoxyphenyl)-3-oxopropyl)malonate (5t). Yield,
40%; white solid; m.p. 88–90 C; IR (KBr, cm1): m 2913–
2986 (CAH), 1738 (AOAC‚O), 1667 (Ar0AC‚O), 1458–
1603 (C‚C and benzene and Py-ring), 1308 (CAN), 1254
(ArACAO), 1179 (ACH2AOAAr0), 1150 (ACH2AOAC‚O),
822 (CACl); 1H NMR (500 MHz, CDCl3, ppm): d 8.41 (d,D-QSAR study of novel chalcone derivatives containing malonate and pyridine
15.05.003
Synthesis, antiviral activity, and 3D-QSAR study of chalcone derivatives 71H, J= 2.00 Hz, Py-2-H), 7.88 (d, 2H, J= 8.80 Hz, Ar0-2,6-
H), 7.71 (dd, 1H, J1 = 2.30 Hz, J2 = 2.50 Hz, Py-4-H), 7.34
(d, 1H, J= 8.20 Hz, Py-5-H), 7.19 (d, 2H, J= 8.60 Hz, Ar-
2,6-H), 6.88 (d, 2H, J= 8.95 Hz, Ar0-3,5-H), 6.82 (d, 2H,
J= 8.65 Hz, Ar-3,5-H), 4.98 (s, 2H, PyACH2A), 4.25–4.06
(m, 5H, ACO2ACH2A, ArACHA, Ar0AOCH2A), 3.96 (q,
2H, ACO2ACH2A), 3.77 (d, 1H, J= 9.75 Hz,
ACO2ACHA), 3.45 (dd, 1H, J1 = 4.40 Hz, J2 = 4.25 Hz,
ACOACHA), 3.33 (dd, 1H, J1 = 9.65 Hz, J2 = 9.70 Hz,
ACOACHA), 1.43 (t, 3H, J1 = 6.90 Hz, J2 = 6.95 Hz,
Ar0AOCH2ACH3), 1.25 (t, 3H, J1 = 7.00 Hz, J2 = 7.20 Hz,
ACO2ACH2ACH3), 1.02 (t, 3H, J1 = 7.20 Hz, J2 = 7.10 Hz,
ACO2ACH2ACH3);
13C NMR (125 MHz, CDCl3, ppm): d
196.1, 168.4, 167.8, 162.9, 157.0, 151.1, 148.7, 138.1, 133.4,
131.6, 130.4, 129.6, 129.5, 124.2, 114.5, 114.1, 66.6, 63.7,
61.7, 61.3, 57.7, 42.4, 40.3, 14.7, 14.1, 13.8; MS (ESI) m/z:
576.4 ([M +Na]+). Anal. Calcd for C30H32ClNO7: C, 65.04;
H, 5.82; N, 2.53. Found: C, 65.24; H, 5.50; N, 3.00.
2.2.2.21. Diethyl 2-(1-(4-((6-chloropyridin-3-yl)methoxy)phe-
nyl)-3-(4-ﬂuorophenyl)-3-oxopropyl)malonate (5u). Yield,
52%; white solid; m.p. 65–67 C; IR (KBr, cm1): m 2932–
3065 (CAH), 1740 (AOAC‚O), 1684 (Ar0AC‚O), 1458–
1599 (C‚C and benzene and Py-ring), 1314 (CAN), 1260
(CAF), 1236 (ArACAO), 1159 (ACH2AOAC‚O), 824
(CACl); 1H NMR (500 MHz, CDCl3, ppm): d 8.40 (d, 1H,
J= 2.00 Hz, Py-2-H), 7.94–7.91 (m, 2H, Ar0-2,6-H), 7.70
(dd, 1H, J1 = 2.30 Hz, J2 = 2.35 Hz, Py-4-H), 7.32 (d, 1H,
J= 8.20 Hz, Py-5-H), 7.19 (d, 2H, J= 8.60 Hz, Ar-2,6-H),
7.09 (t, 2H, J1 = 8.55 Hz, J2 = 8.60 Hz, Ar
0-3,5-H), 6.83 (d,
2H, J= 8.60 Hz, Ar-3,5-H), 4.98 (s, 2H, PyACH2A), 4.26–
4.15 (m, 2H, ACO2ACH2A), 4.13–4.09 (m, 1H, ArACHA),
3.97 (q, 2H, ACO2ACH2A), 3.78 (d, 1H, J= 9.65 Hz,
ACO2ACHA), 3.51 (dd, 1H, J1 = 4.35 Hz, J2 = 4.20 Hz,
ACOACHA), 3.37 (dd, 1H, J= 9.6 Hz, ACOACHA), 1.25
(t, 3H, J1 = 7.15 Hz, J2 = 7.05 Hz, ACO2ACH2ACH3), 1.03
(t, 3H, J1 = 7.15 Hz, J2 = 7.05 Hz, ACO2ACH2ACH3);
13C
NMR (125 MHz, CDCl3, ppm): d 196.2, 168.4, 167.8, 166.8,
164.8, 157.2, 151.2, 148.8, 138.2, 135.1, 133.3, 131.7, 130.9,
130.8, 129.5, 124.3, 115.8, 115.6, 114.8, 66.7, 61.8, 61.4, 57.7,
42.8, 40.3, 14.1, 13.9; 19F NMR (470 MHz, CDCl3, ppm): d
105.10; MS (ESI) m/z: 550.3 ([M+ Na]+). Anal. Calcd for
C28H27ClFNO6: C, 63.70; H, 5.15; N, 2.65. Found: C, 63.33;
H, 5.34; N, 2.70.
2.2.2.22. Diethyl 2-(1-(4-((6-chloropyridin-3-yl)methoxy)phe-
nyl)-3-(4-isopropylphenyl)-3-oxopropyl)malonate (5v). Yield,
45%; white solid; m.p. 80–82 C; IR (KBr, cm1): v 2874–
2974 (CAH), 1728 (AOAC‚O), 1676 (Ar0AC‚O), 1458–
1609 (C‚C and benzene and Py-ring), 1292 (CAN), 1238
(ArACAO), 1157 (ACH2AOAC‚O), 824 (CACl);
1H NMR
(500 MHz, CDCl3, ppm): d 8.41 (d, 1H, J= 2.30 Hz, Py-2-
H), 7.84 (d, 2H, J= 8.25 Hz, Ar0-2,6-H), 7.71 (dd, 1H,
J1 = 2.50 Hz, J2 = 2.40 Hz, Py-4-H), 7.34 (d, 1H,
J= 8.25 Hz, Py-5-H), 7.28 (d, 2H, J= 8.40 Hz, Ar-2,6-H),
7.20 (d, 2H, J= 8.65 Hz, Ar0-3,5-H), 6.82 (d, 2H,
J= 8.75 Hz, Ar-3,5-H), 4.98 (s, 2H, PyACH2A), 4.24–4.11
(m, 3H, ACO2ACH2A, ArACHA), 3.96 (q, 2H,
ACO2ACH2A), 3.78 (d, 1H, J= 9.75 Hz, ACO2ACHA),
3.48 (dd, 1H, J1 = J2 = 4.30 Hz, ACOACHA), 3.39 (dd,
1H, J1 = J2 = 9.60 Hz, ACOACHA), 2.97–2.92 (m, 1H,
Ar0ACHA), 1.26–1.24 (m, 9H, Ar0ACHA(CH3)2,Please cite this article in press as: Chen, Z. et al., Synthesis, antiviral activity, and 3D
moieties. Arabian Journal of Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.20ACO2ACH2ACH3), 1.03 (t, 3H, J1 = 7.15 Hz, J2 = 7.05 Hz,
ACO2ACH2ACH3);
13C NMR (125 MHz, CDCl3, ppm): d
197.2, 168.4, 167.8, 157.0, 154.6, 151.1, 148.7, 138.1, 134.6,
133.5, 131.6, 129.5, 128.4, 126.7, 124.2, 114.6, 66.6, 61.7,
61.4, 57.7, 42.6, 40.1, 34.2, 23.7, 14.1, 13.8; MS (ESI) m/z:
574.4 ([M+ Na]+). Anal. Calcd for C31H34ClNO6: C, 67.44;
H, 6.21; N, 2.54. Found: C, 67.25; H, 6.10; N, 2.61.
2.3. Antiviral activities against CMV
2.3.1. Puriﬁcation of CMV
Nicotiana tabacum L. leaves inoculated with CMV were
selected, ground in phosphate butter, and then ﬁltered through
a double-layer pledget by using the method of Zhou et al.
(1995). The ﬁltrate was centrifuged at 8000g, and the super-
natant liquid was collected as the crude extract of the virus.
All of the experiments were performed at 4 C.
The virus concentration was calculated as
Virus concentration ðmg=mLÞ¼ ðA260dilution ratioÞ=E 0:1% 260 nm1 cm
where E represents the extinction coefﬁcient of TMV and
E 0:1% 260 nm1 cm is 3.1.
2.3.2. Curative activities of the title compounds against CMV
in vivo
Leaves of the same age were gathered from Chenopodium ama-
ranticolor. Crude CMV (6 · 103 mg/mL) was inoculated
using a brush on whole leaves on which silicon carbide had
previously been scattered. After 0.5–1 h, the leaves were
washed with water and dried. The compound solution was
then smeared on the right side of leaves, and solvent was
smeared on the left side as a control. The number of local
lesions that developed was recorded 3–4 d after inoculation.
All compounds were tested with three repetitions to ensure
accuracy in the results.
2.3.3. Protection activities of the title compounds against CMV
in vivo
Leaves of C. amaranticolor of the same age were selected. The
compound solution was smeared on the right side of the
leaves. Meanwhile, the solvent was smeared on the left side
as control. After 12 h, crude CMV, at the concentration of
6 · 103 mg/mL, was inoculated with a brush on whole leaves,
which had previously been scattered with silicon carbide. After
0.5–1 h, the leaves were washed with water and dried. The
number of local lesions was then recorded 3–4 d after inocula-
tion. All compounds were tested with three repetitions to
ensure veracity of the results.
2.3.4. Inactivation activities of the title compounds against CMV
in vivo
The virus was inhibited by mixing with the compound solution
at the same volume for 0.5 h. The right side of C. amaranti-
color leaves was then inoculated with the mixture and CMV
diluted to suitable concentration (6 · 103 mg/mL) was inocu-
lated on the left side as control, of leaves that had previously
been scattered with silicon carbide. After 0.5–1 h, the leaves
were washed with water and dried. The number of local lesions
was recorded 3–4 d after inoculation. All compounds were
tested with three repetitions to ensure veracity of the results.-QSAR study of novel chalcone derivatives containing malonate and pyridine
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Table 1 Selection of conditions for the reaction of the target compound 5l.
Entry Solvent Catalyst Molar equivalent (4a:diethyl malonate:catalyst) T (C) t (h) Yield (%)
1 EtOH KOH 1:1:0.5 80 4 37.4
2 EtOH KOH 1:1:1 80 2 44.9
3 EtOH KOH 1:2:1 80 1 61.0
4 EtOH KOH 1:5:1 80 0.5 71.2
5 EtOH KOH 1:5:1 20 12 43.4
6 EtOH KOH 1:5:1 40 8 56.7
7 EtOH KOH 1:5:1 60 3 62.2
8 THF KOH 1:5:1 65 3 –a
9 EtOH NaOH 1:5:1 80 1 68.0
10 EtOH KOH 1:5:1 80 3 10.6
a No reaction.
8 Z. Chen et al.The inhibitory rates of the target compounds were calculated
according to the following formula (‘‘av’’ means average):
Inhibition rate (%) = [(av local lesion no of control (not
treated with compound solution)  av local lesion no smeared
with drugs)/av local lesion no of control (not treated with com-
pound solution)] · 100%.
2.4. 3D-QSAR analysis
2.4.1. Datasets for 3D-QSAR analysis
The data of 22 target compounds were obtained, and biologi-
cal activity was expressed as pEC50. A total of 16 compoundsTable 2 Antiviral activities of the target compounds against CMV
Compd. Curative act
R1 R2
5a H ACH3 31.0 ± 2.4
5b 2-CH3 ACH3 29.1 ± 1.7
5c 3-CH3 ACH3 39.1 ± 2.0
5d 4-CH3 ACH3 53.8 ± 1.6
5e 2-Cl ACH3 57.5 ± 1.1
5f 3-Cl ACH3 48.0 ± 2.1
5g 4-Cl ACH3 29.2 ± 1.4
5h 2,4-di-Cl ACH3 26.7 ± 2.0
5i 4-OC2H5 ACH3 28.9 ± 0.5
5j 4-F ACH3 25.4 ± 0.9
5k 4-i-Pr ACH3 38.9 ± 0.8
5l H AC2H5 69.8 ± 1.8
5m 2-CH3 AC2H5 55.5 ± 1.6
5n 3-CH3 AC2H5 65.0 ± 3.9
5o 4-CH3 AC2H5 54.1 ± 0.7
5p 2-Cl AC2H5 46.6 ± 1.3
5q 3-Cl AC2H5 56.4 ± 1.8
5r 4-Cl AC2H5 31.4 ± 1.8
5s 2,4-di-Cl AC2H5 33.3 ± 0.9
5t 4-OC2H5 AC2H5 33.3 ± 0.9
5u 4-F AC2H5 34.6 ± 1.4
5v 4-i-Pr AC2H5 50.4 ± 2.2
Ningnanmycinb 56.9 ± 0.9
a Average of three replicates.
b The commercial antiviral product ningnanmycin was used for activity
Please cite this article in press as: Chen, Z. et al., Synthesis, antiviral activity, and 3
moieties. Arabian Journal of Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.20(labeled with asterisks) were randomly chosen as the training
set for CoMFA (Cramer et al., 1988), and the remaining 6
compounds were used as the testing set.
2.4.2. Molecular modeling and alignment
Molecular modeling and CoMFA analysis were performed
using SYBYL 7.3 (Tripos Inc., St. Louis, MO, USA) software.
The 3D structures of all molecules were built using the Sketch
Molecule function in SYBYL. Initial optimization of the
structures was conducted using the Gasteiger–Hu¨ckel
charge, Tripos force ﬁeld, and Powell conjugate gradient
algorithm with a convergence criterion of 0.005 kcal/mol A˚in vivo at 500 lg/mL.
ivity (%)a Protection activity (%)a Inactivation activity (%)a
28.6 ± 2.1 78.5 ± 1.7
40.0 ± 2.1 82.3 ± 1.7
25.8 ± 1.9 79.1 ± 1.7
26.0 ± 2.1 78.3 ± 1.8
12.7 ± 3.3 75.8 ± 1.1
37.7 ± 2.1 81.1 ± 1.6
24.6 ± 1.5 69.1 ± 2.1
19.5 ± 1.3 67.2 ± 2.4
42.7 ± 2.6 74.9 ± 1.7
38.2 ± 2.0 68.9 ± 1.5
43.7 ± 2.1 67.2 ± 1.6
39.1 ± 2.6 88.1 ± 1.5
37.1 ± 2.6 84.4 ± 1.9
54.9 ± 1.4 88.6 ± 1.2
24.2 ± 1.5 83.3 ± 1.5
50.1 ± 1.2 73.0 ± 2.4
41.2 ± 2.7 86.2 ± 1.8
29.5 ± 1.0 75.2 ± 2.1
22.1 ± 1.0 72.3 ± 2.1
46.9 ± 1.7 70.0 ± 2.3
39.3 ± 0.8 78.6 ± 1.2
28.0 ± 2.1 64.8 ± 2.5
58.3 ± 0.8 92.2 ± 0.9
comparison.
D-QSAR study of novel chalcone derivatives containing malonate and pyridine
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Table 3 EC50 and pEC50 values of the target compounds against CMV in vivo.
Compd. EC50 (lg/mL)
a pEC50 (lM)
R1 R2
5a H CH3 1262.79 ± 4.7 2.581
5b 2-CH3 CH3 1282.19 ± 2.9 2.587
5c 3-CH3 CH3 792.25 ± 3.2 2.796
5d 4-CH3 CH3 430.46 ± 1.9 3.061
5e 2-Cl CH3 328.97 ± 2.1 3.196
5f 3-Cl CH3 495.48 ± 1.3 3.017
5g 4-Cl CH3 1251.87 ± 2.5 2.614
5h 2,4-di-Cl CH3 1728.63 ± 3.1 2.502
5i 4-OC2H5 CH3 1301.58 ± 4.3 2.606
5j 4-F CH3 2066.61 ± 2.6 2.383
5k 4-i-Pr CH3 803.08 ± 3.4 2.814
5l H C2H5 186.17 ± 3.2 3.437
5m 2-CH3 C2H5 400.68 ± 2.5 3.116
5n 3-CH3 C2H5 211.47 ± 3.5 3.393
5o 4-CH3 C2H5 426.93 ± 3.1 3.088
5p 2-Cl C2H5 548.26 ± 2.8 2.996
5q 3-Cl C2H5 338.09 ± 2.7 3.206
5r 4-Cl C2H5 1213.43 ± 3.8 2.651
5s 2,4-di-Cl C2H5 1132.99 ± 2.3 2.707
5t 4-OC2H5 C2H5 1053.92 ± 3.6 2.720
5u 4-F C2H5 942.08 ± 3.7 2.748
5v 4-i-Pr C2H5 466.88 ± 4.6 3.072
Ningnanmycinb 330.52 ± 1.7
a Average of three replicates.
b Commercial, agricultural, and antiviral ningnanmycin products were used for activity comparison.
Synthesis, antiviral activity, and 3D-QSAR study of chalcone derivatives 9(Huang et al., 2011). The 3D structures of the 22 molecules
were aligned to the common template molecule of 5l to reveal
the best curative activity against CMV in the CoMFA model
study.
2.4.3. Partial least-squares analysis
3D-QSAR was derived using partial least square (PLS) analy-
sis wherein molecules were placed in a rectangular grid, and
interaction energies between a probe atom and all compounds
were computed at surrounding points by using a volume-
dependent lattice with a 2.0 grid spacing (default in SYBYL)
to improve the signal-to-noise ratio (Elizabeth and William,
2006). CoMFA descriptors were used as independent vari-
ables, and experimental pEC50 values were presented as the
dependent variables. 3D-QSAR analysis was then conducted
in two steps by using the PLS technique. First, the perfor-
mance of the models was evaluated by leave-one-out cross-
validation, and the optimal number of components (ONC)
was determined with the highest cross-validated q2 (Baroni
et al., 1992). The non-cross-validated correlation coefﬁcient
r2, standard error of estimate (SEE), and F were subsequently
calculated according to the deﬁnitions in the SYBYL 7.3 pack-
age. Contour maps and standard deviations of CoMFA were
generated by using PLS coefﬁcients.Please cite this article in press as: Chen, Z. et al., Synthesis, antiviral activity, and 3D
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3.1. Chemistry
High product yields, good molar equivalence, suitable reaction
temperatures, and short reaction times encouraged us to apply
previously reported methods under optimized reaction condi-
tions with the aim of synthesizing title compounds. Thus, the
reactions were carried out using the key intermediate 4a and
diethyl malonate as the starting materials and the synthesis
of the target compound 5l as the model reaction. The effects
of different reaction solvents, catalysts, molar equivalents,
and reaction temperatures on the yields and reaction times
of the target compounds were determined. As shown in
Table 1, the highest yield (71.2%) and shortest reaction time
(0.5 h) were obtained when the reaction solvent, catalyst,
molar equivalent, and reaction temperature were C2H5OH,
KOH, 1:5:1, and 80 C, respectively. Therefore, the target
compounds 5a–5v were synthesized under the following opti-
mal conditions: solvent, C2H5OH (CH3OH); catalyst, KOH;
temperature, 80 C; and molar equivalent of 4: diethyl
(dimethyl) malonate:catalyst, 1:5:1. The IR spectra of com-
pounds 5a–5v showed characteristic absorption bands at
2837–3088 cm1, which reveals the presence of CAH. The-QSAR study of novel chalcone derivatives containing malonate and pyridine
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Table 4 Experimental and predicted pEC50 results against
CMV.
Compd. Experimentala Predictedb Residualc
*5a 2.581 2.597 0.016
5b 2.587 2.584 0.003
*5c 2.796 2.800 0.004
*5d 3.061 3.046 0.015
*5e 3.196 3.161 0.035
*5f 3.017 3.043 0.026
*5g 2.614 2.599 0.015
5h 2.502 2.481 0.021
*5i 2.606 2.611 0.005
*5j 2.383 2.399 0.016
*5k 2.814 2.796 0.018
*5l 3.437 3.427 0.010
*5m 3.116 3.124 0.008
5n 3.393 3.465 0.072
5o 3.088 3.338 0.250
*5p 2.996 3.053 0.057
5q 3.206 3.353 0.153
*5r 2.651 2.680 0.029
*5s 2.707 2.642 0.065
*5t 2.720 2.723 0.003
*5u 2.748 2.741 0.007
5x 3.072 3.185 0.113
a Experimental pEC50.
b Predicted by CoMFA.
c Relative error of the experimentally predicted pEC50 (b–a).
* Samples of the training set.
10 Z. Chen et al.stretching frequency at 1663–1749 cm1 was assigned to C‚O
vibrations. Bands at 1150–1262 and 818–833 cm1 revealed the
respective stretching vibrations of CAO and CACl groups of
the chalcone skeleton. 1H NMR spectra showed one sharp
peak appearing at 4.95–5.01 ppm, which indicates the presence
of PyACH2A, and a doublet appearing at 3.72–3.84 ppm,
which indicates the presence of ACHA(CO2R2)2. Chemical
shifts at approximately 197.6, 168.7, and 168.2 ppm in 13C
NMR spectra conﬁrmed the presence of C‚O; a chemical
shift at approximately 66.6 ppm conﬁrmed the presence of
PyACH2A.Figure 1 Graph of predicted pEC50 versus experimental pEC50
for the CoMFA model.
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The antiviral activities of the target compounds 5a–5v against
CMV were assayed with ningnanmycin as the control. Table 2
shows that most of the title compounds present moderate to
good antiviral activity against CMV in vivo. In particular,
among the compounds tested, 5l and 5n exhibited excellent
curative activities with inhibition rates as high as 69.8% and
65.0% at 500 lg/mL; these rates are better than that reported
for ningnanmycin (56.9%). Compounds 5l and 5n showed
increased CMV inactivation rates of 88.1% and 88.6%, respec-
tively, which are nearly similar to that of ningnanmycin
(92.2%). Compound 5n also possessed good protective activity
against CMV, with an inhibition rate of 54.9% at 500 lg/mL;
this rate is only slightly lower than that of ningnanmycin
(58.3%).
Using the results of preliminary bioassays as bases, the
EC50 values of the title compounds were evaluated and are
summarized in Table 3. Compounds 5l and 5n exhibited nota-
ble curative activities against CMV with EC50 values of 186.2
and 211.5 lg/mL, respectively; these values are even better
than that of ningnanmycin (330.5 lg/mL).
3.3. Performance of the CoMFA model
A CoMFA model based on the experimental EC50 values of
the training set was developed for the 3D-QSAR study. The
predicted and experimental pEC50 values of compounds in
both the training and testing sets are presented in Table 4,
and correlations between the predicted and experimental
pEC50 values in the CoMFA model are presented in Fig. 1.
Overall, the predicted pEC50 values were very similar to the
corresponding experimental values among compounds in both
the training and testing sets (Table 4). The mostly linear corre-
lation in Fig. 1 demonstrated the high predictive power of the
developed model. The calculated statistical parameters of the
CoMFA model are shown in Table 5. The cross-validated
coefﬁcient q2, non-cross-validated correlation coefﬁcient r2,
SEE, and F of the model were 0.517 (>0.5) with 6 ONC,
0.990, 0.036, and 143.396, respectively. The relative contribu-
tions of steric and electrostatic to the CoMFA model were
0.658 and 0.342, respectively; these values suggest that bioac-
tivity is mainly determined by steric interactions.Table 5 Statistical parameters for the CoMFA model.
Statistical parameter CoMFA
q2a 0.517
ONCb 6
r2c 0.990
SEEd 0.036
Fe 143.396
Fraction of ﬁeld contributionsf
Steric 0.658
Electrostatic 0.342
a Cross-validated correlation.
b Optimum number of components.
c Noncross-validated correlation.
d Standard error of estimate.
e F-test value.
f Field contributions: steric and electrostatic.
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Figure 2 CoMFA contour maps of the steric (A) and electrostatic (B) ﬁelds.
Synthesis, antiviral activity, and 3D-QSAR study of chalcone derivatives 11CoMFA contour maps of the steric and electrostatic ﬁelds
for antiviral activity against CMV are shown in Fig. 2. Green
contours in the CoMFA steric ﬁeld indicate regions where
bulky groups increase activity, whereas yellow contours indi-
cate regions where bulky groups decrease activity. Fig. 2A
shows two large yellow contours around the benzene ring; this
result indicates that bulky substituent groups at the position of
R1 are unfavorable. For example, a molecule with a Ph (i.e., 5l)
substituent showed better activity than that with a 4-OC2H5-
Ph (5t) moiety at the R1 position. A green contour was found
near the R2 substituent position, which suggests that bulky
groups are favorable at this position. The results of the con-
tour map agreed well with experimental data showing that
replacement of methyl with ethyl at the R2 substituent position
results in increases in activity following the order of 5l> 5a,
5m> 5b, and 5n> 5c. An electrostatic contour map of the
CoMFA model is displayed in Fig. 2B; here, blue contours
indicate regions where electron-withdrawing groups would
increase activity and red contours indicate regions where
electron-donating groups would increase activity. As shown
in Fig. 2B, several large regions of the red contours were
observed near the phenyl ring, which indicates that electron-
donating substituent groups at the position of the phenyl ring
help increase the activity of the compounds. The contour maps
agreed well with experimental data showing that replacement
of AF with AH or ACH3 at the R1 substituent position on
the phenyl ring results in increases in activity following the
order of 5l> 5u and 5o> 5u.4. Conclusion
In summary, novel chalcone derivatives containing malonate
and pyridine moieties were prepared and evaluated in terms
of their antiviral activities against CMV. The structures of
all of the compounds were identiﬁed using spectral data (1H
NMR, 13C NMR, 19F NMR, MS, and IR) and elemental anal-
yses. Bioassay results showed that most of the compounds pos-
sess good antiviral activity against CMV in vivo; in particular,
compounds 5l and 5n exhibited higher curative activities than
ningnanmycin. The CoMFA model established based on the
anti-CMV activities of the target compounds showed high pre-
dictive ability. The present work successfully demonstratedPlease cite this article in press as: Chen, Z. et al., Synthesis, antiviral activity, and 3D
moieties. Arabian Journal of Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.20that chalcone derivatives containing malonate and pyridine
moieties can effectively control CMV. Further studies on the
structural optimization and modes of action of these com-
pounds are ongoing in our laboratory.
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